Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Advanced Laboratory Medicine, |
RCV000852758 | SCV000995476 | likely benign | Cardiomyopathy | 2019-05-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002363201 | SCV002663392 | uncertain significance | Cardiovascular phenotype | 2024-06-03 | criteria provided, single submitter | clinical testing | The c.658G>A (p.G220R) alteration is located in exon 6 (coding exon 6) of the TRPM4 gene. This alteration results from a G to A substitution at nucleotide position 658, causing the glycine (G) at amino acid position 220 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |